Evidence map›Paper›PMID 42653969›Full record

ArticleMolecules (Basel, Switzerland)2026

In Vitro Synergistic Effects of Selected Essential Oil Components Against Clinical

Magdalena Szemraj, Barbara Kot, Kamila Olszowiec, Zuzanna Walczak, Małgorzata Piechota, Małgorzata Witeska, Monika Sienkiewicz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Magdalena SzemrajDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-419 Łódź, Poland.ORCID 0000-0002-1986-2220
Barbara KotInstitute of Biological Sciences, Faculty of Exact and Natural Sciences, University of Siedlce, 14 Bolesława Prusa Str., 08-110 Siedlce, Poland.
Kamila OlszowiecDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-419 Łódź, Poland.
Zuzanna WalczakDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-419 Łódź, Poland.
Małgorzata PiechotaInstitute of Biological Sciences, Faculty of Exact and Natural Sciences, University of Siedlce, 14 Bolesława Prusa Str., 08-110 Siedlce, Poland.
Małgorzata WiteskaDepartment of Animal Environment Biology, Institute of Animal Science, Warsaw University of Life Sciences-SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland.ORCID 0000-0002-3631-4701
Monika SienkiewiczDepartment of Pharmaceutical Microbiology and Microbiological Diagnostics, Medical University of Lodz, 90-419 Łódź, Poland.ORCID 0000-0002-9823-4176

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsOils, VolatileAcyclic MonoterpenesAllylbenzene DerivativesAnisolesCymenesDrug Resistance, Multiple, BacterialDrug SynergismEucalyptolEugenolHumansMicrobial Sensitivity TestsMonoterpenesAcyclic MonoterpenesAllylbenzene DerivativesanetholeAnisolesAnti-Bacterial AgentscarvacrolcitronellolCymenesEucalyptolEugenolgeraniollinaloolMonoterpenesOils, VolatileAcinetobacter baumanniiessential oil componentsfractional inhibitory concentration (FICI)multidrug-resistant bacteriasynergistic interactions

Identifiers

PMID42653969
PMCPMC13515966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.